ANI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	17.15	-49.52	-42.79	-22.55	6.09	15.49	-1.08	3.93	15.38	28.75
Depreciation & Amortization	61.06	59.65	47.25	44.64	44.61	33.74	27.93	22.34	6.9	3.88
Share-Based Compensation	20.65	14.6	10.49	12.94	9.22	6.78	6.09	6.07	3.86	3.42
Other Operating Activities	18.47	-57.56	-11.82	-19.76	-14.29	11.06	6.48	-4.87	-8.87	-14.02
Operating Cash Flow	118.96	-31.2	3.32	15.27	45.63	67.07	39.42	27.47	17.26	22.03
Operating Cash Flow Growth	-	-	-78.24%	-66.54%	-31.97%	70.16%	43.49%	59.13%	-21.64%	-
Capital Expenditures	-8.87	-8.13	0.09	-6.14	-6.64	-5.74	-10.37	-4.57	-32.68	-35.75
Acquisitions	-9.64	-7.61	-105.58	-62.19	-20.91	-21.64	-97.62	-144.49	0	0
Investing Cash Flow	-18.51	-15.74	-105.48	-68.32	-27.55	-27.38	-107.99	-149.06	-32.68	-35.75
Share Issuance / Repurchase	84.56	-0.5	70.76	-0.91	4.71	2.32	0.09	-1.05	0.71	47.5
Debt Issued / Paid	-3	-3	99.02	-0.53	-3.46	-30.51	72.26	-0.29	0	138.24
Other Financing Activities	-14.13	-1.63	24.81	-	-	0.38	-	0.62	0.36	-14.09
Financing Cash Flow	67.44	-5.13	194.6	-1.44	1.25	-27.82	72.36	-0.73	1.07	171.65
Net Cash Flow	167.89	-52.07	92.43	-54.49	19.33	11.88	3.78	-122.32	-14.35	157.93
Free Cash Flow	110.09	-39.33	3.41	9.13	39	61.33	29.05	22.91	-15.42	-13.72
Free Cash Flow Growth	-	-	-62.61%	-76.58%	-36.42%	111.12%	26.82%	-	-	-
Free Cash Flow Margin	22.61%	-12.43%	1.58%	4.38%	18.88%	30.43%	16.43%	17.81%	-20.20%	-24.51%
Free Cash Flow Per Share	6.05	-2.42	0.27	0.76	3.24	5.21	2.52	1.98	-1.33	-1.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).